A novel tool known as the Florey Dementia Index (FDI) predicted onset age of mild cognitive impairment or Alzheimer's disease ...
Declining blood levels of two molecules that occur naturally in the body track closely with worsening Alzheimer’s disease, particularly in women. Levels were found to drop gradually, from women with ...
Discover a groundbreaking study that may help detect Alzheimer's in its early stages. Learn about the link between blood ...
The EAPP test, which runs on Roche’s widely ... Eli Lilly has another approval for its anti-amyloid therapy for Alzheimer's disease, Kisunla, in China – the world's second-largest drugs ...
A predictive tool for determining the age at which individuals may develop mild cognitive impairment (MCI) or Alzheimer's ...
In one study reported this year, a specific blood test was around 90% accurate in identifying Alzheimer’s in patients with cognitive symptoms seen in primary care and at specialized memory care ...
Declining blood levels of two molecules that occur naturally in the body track closely with worsening Alzheimer's disease, ...
The latter drug was filed for approval in the UK in July for the treatment of mild cognitive impairment and mild to moderate Alzheimer's. Eli Lilly has another approval for its anti-amyloid ...
Researchers have linked herpes simplex virus-1 with Alzheimer's disease, revealing a surprising potential viral trigger for the neurodegenerative condition. Their study suggests that the tau protein, ...